Adequate Information. The Investor has received from the Issuer, and has reviewed, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC Reports. The Investor acknowledges that each of the SEC Reports are specifically incorporated herein by reference and form an integral part of this Agreement. The Investor also acknowledges that the risk factors contained in the SEC Reports are specifically incorporated herein by reference and forms an integral part of this Agreement.
Appears in 2 contracts
Sources: Subscription Agreement (CDSS Wind Down Inc), Subscription Agreement for Convertible Notes (CDSS Wind Down Inc)
Adequate Information. The Investor has received from the Issuer, and has reviewedhad the opportunity to review, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC Reports. The Investor acknowledges that each of the SEC Reports are specifically incorporated herein by reference Shares and form an integral part of this AgreementWarrants. The Investor also acknowledges that the risk factors set forth on Exhibit C and contained in the SEC Reports are specifically incorporated herein by reference have been delivered to the Investor and forms an integral part of this Agreementthe Investor has had the opportunity to review such risk factors.
Appears in 2 contracts
Sources: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Adequate Information. The Investor has received from the Issuer, and has reviewedhad the opportunity to review, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC Reports. The Investor acknowledges that each of the SEC Reports are specifically incorporated herein by reference and form an integral part of this AgreementNotes. The Investor also acknowledges that the additional risk factors set forth on Exhibit D and contained in the SEC Reports are specifically incorporated herein by reference have been delivered to the Investor and forms an integral part of this Agreementthe Investor has had the opportunity to review such risk factors.
Appears in 2 contracts
Sources: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Adequate Information. The Investor has received from the Issuer, and has reviewed, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC Reports. The Investor also acknowledges that each of the additional risk factors set forth on Exhibit D and contained in the SEC Reports are specifically incorporated herein by reference and form an integral part of this Agreement. The Investor also acknowledges that the risk factors contained in the SEC Reports are specifically incorporated herein by reference and forms an integral part of this Agreement.
Appears in 2 contracts
Sources: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Adequate Information. The Investor has received from the Issuer, and has reviewed, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC ReportsShares and Warrants. The Investor also acknowledges that each of the additional risk factors set forth on Exhibit B and contained in the SEC Reports are specifically incorporated herein by reference and form an integral part of this Agreement. The Investor also acknowledges that the risk factors contained in the SEC Reports are specifically incorporated herein by reference and forms an integral part of this Agreement.
Appears in 2 contracts
Sources: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Adequate Information. The Investor has received from the Issuer, and has reviewed, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC Reports. The Investor also acknowledges that each of the additional risk factors set forth on Exhibit C and contained in the SEC Reports are specifically incorporated herein by reference and form an integral part of this Agreement. The Investor also acknowledges that the risk factors contained in the SEC Reports are specifically incorporated herein by reference and forms an integral part of this Agreement.
Appears in 1 contract
Adequate Information. The Investor has received from the Issuer, and has reviewed, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC ReportsDisclosure Schedule to this Agreement, which have been received by the Investor as part of an informational packet of materials from the Issuer (the “Disclosure Documents”). The Investor acknowledges that each of the SEC Reports Reports, including the risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreement. The Investor also acknowledges that the risk factors contained in the SEC Reports are specifically incorporated herein by reference and forms an integral part of this Agreement.
Appears in 1 contract
Adequate Information. The Investor has received from the Issuer, and has reviewed, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC ReportsDisclosure Documents. The Investor acknowledges that each of the SEC Reports are specifically incorporated herein by reference and form an integral part of this Agreement. The Investor also acknowledges that the risk factors contained in the SEC Reports are specifically incorporated herein by reference and forms an integral part of this Agreement. The Investor also acknowledges that the additional risk factors set forth on Exhibit B and contained in the Disclosure Documents are specifically incorporated herein by reference and form an integral part of this Agreement.
Appears in 1 contract
Adequate Information. The Investor has received from the Issuer, and has --------------------- reviewed, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC Reports. The documents listed on Exhibit C. Investor acknowledges that each the --------- information set forth under the heading of the SEC Reports are specifically incorporated herein by reference and form an integral part of this Agreement. The Investor also acknowledges that the risk factors contained "RISK FACTORS" in the SEC Reports are Exhibit D hereto is --------- specifically incorporated herein by reference and forms an integral part of this Agreement.
Appears in 1 contract
Adequate Information. The Such Investor has received from the Issuer, and has reviewed, such information which the such Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the information set forth on Exhibit A and the SEC Reports. The Such Investor acknowledges that each of the SEC Reports Reports, including the risk factors contained therein, are specifically incorporated herein by reference and form an integral part of this Agreement. The Such Investor also acknowledges that the additional risk factors contained in the SEC Reports set forth on Exhibit A are specifically incorporated herein by reference and forms form an integral part of this Agreement.
Appears in 1 contract
Sources: Purchase Agreement (Path 1 Network Technologies Inc)
Adequate Information. The Investor has received from the Issuer, and has reviewedhad the opportunity to review, such information which the Investor considers necessary or appropriate to evaluate the risks and merits of an investment in the Shares, including without limitation, the SEC Reports. The Investor acknowledges that each of the SEC Reports are specifically incorporated herein by reference and form an integral part of this AgreementNotes. The Investor also acknowledges that the additional risk factors set forth on Exhibit C and contained in the SEC Reports are specifically incorporated herein by reference have been delivered to the Investor and forms an integral part of this Agreementthe Investor has had the opportunity to review such risk factors.
Appears in 1 contract